|
Millon Clinical Multiaxial Inventory
|
F04.711.647.513.535 |
|
|
Yang Deficiency
|
C23.550.945 |
|
|
Carbamoyl-Phosphate Synthase I Deficiency Disease
|
C10.228.140.163.100.937.249 |
|
|
Data Anonymization
|
N04.452.910.200.500 |
|
|
Olfactory Cortex
|
A08.186.211.200.885.287.500.814.695 |
|
|
Round Window, Ear
|
A09.246.300.246.814 |
|
|
Physalis
|
B01.650.940.800.575.912.250.908.500.499 |
|
|
Argininosuccinate Synthase
|
D08.811.464.259.300 |
|
|
Oligoribonucleotides, Antisense
|
D13.444.735.150.640 |
|
|
Activated Protein C Resistance
|
C15.378.925.050 |
|
|
Activation, Metabolic
|
G03.787.225.224 |
|
|
Contraceptive Agents, Male
|
D27.505.696.875.360.443 |
|
|
Carbonic Anhydrase IV
|
D12.776.543.550.418.160 |
|
|
ADP-ribosyl Cyclase 1
|
D08.811.277.450.430.400.060.500 |
|
|
Cytochrome P-450 CYP2B6 Inhibitors
|
D065686 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2B6.
] |
|
Cytochrome P-450 CYP2C8 Inhibitors
|
D065687 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C8.
] |
|
Cytochrome P-450 CYP2C9 Inhibitors
|
D065688 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.
] |
|
Paraganglia, Nonchromaffin
|
A08.800.950.500.600 |
|
|
Cytochrome P-450 CYP2C19 Inhibitors
|
D065689 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C19.
] |
|
Hysteroscopy
|
E04.950.300.539 |
|
